JP2018507254A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507254A5
JP2018507254A5 JP2017558627A JP2017558627A JP2018507254A5 JP 2018507254 A5 JP2018507254 A5 JP 2018507254A5 JP 2017558627 A JP2017558627 A JP 2017558627A JP 2017558627 A JP2017558627 A JP 2017558627A JP 2018507254 A5 JP2018507254 A5 JP 2018507254A5
Authority
JP
Japan
Prior art keywords
seq
variable region
chain variable
light chain
slc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017558627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/015166 external-priority patent/WO2016126488A1/en
Publication of JP2018507254A publication Critical patent/JP2018507254A/ja
Publication of JP2018507254A5 publication Critical patent/JP2018507254A5/ja
Pending legal-status Critical Current

Links

JP2017558627A 2015-02-02 2016-01-27 抗代替軽鎖抗体 Pending JP2018507254A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562111018P 2015-02-02 2015-02-02
US62/111,018 2015-02-02
PCT/US2016/015166 WO2016126488A1 (en) 2015-02-02 2016-01-27 Anti-surrogate light chain antibodies

Publications (2)

Publication Number Publication Date
JP2018507254A JP2018507254A (ja) 2018-03-15
JP2018507254A5 true JP2018507254A5 (OSRAM) 2019-02-28

Family

ID=56564528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017558627A Pending JP2018507254A (ja) 2015-02-02 2016-01-27 抗代替軽鎖抗体

Country Status (10)

Country Link
US (1) US10858448B2 (OSRAM)
EP (2) EP3253793A4 (OSRAM)
JP (1) JP2018507254A (OSRAM)
KR (1) KR102590740B1 (OSRAM)
CN (1) CN107849123A (OSRAM)
AU (1) AU2016215676B2 (OSRAM)
CA (2) CA2975346A1 (OSRAM)
HK (1) HK1247941A1 (OSRAM)
IL (1) IL253579A0 (OSRAM)
WO (1) WO2016126488A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016126488A1 (en) 2015-02-02 2016-08-11 Sea Lane Biotechnologies, Llc Anti-surrogate light chain antibodies
WO2016127043A1 (en) 2015-02-05 2016-08-11 Stc.Unm Anti-pre-bcr antagonists and methods
AU2017366739B2 (en) 2016-12-02 2023-11-23 Angeles Therapeutics, Inc. Synthetic immune receptors and methods of use thereof
US11407828B2 (en) * 2019-02-01 2022-08-09 Novarock Biotherapeutics, Ltd. Anti-CLauDiN 18 antibodies and methods of use thereof
CA3138550A1 (en) * 2019-04-30 2020-11-05 Target Discovery Merger Sub II, LLC Cancer associated antibody compositions and methods of use
CN112300282A (zh) * 2020-11-03 2021-02-02 南京北恒生物科技有限公司 靶向cd7的人源化抗体及其用途
IL305188A (en) * 2021-02-16 2023-10-01 Childrens Health Care D/B/A Childrens Minnesota Methods for treating B-ALL by administering a pre-BCR complex antagonist
JP2025534161A (ja) * 2022-10-04 2025-10-14 ミンク セラピューティクス, インコーポレイテッド 線維芽細胞活性化タンパク質(fap)carインバリアントナチュラルキラーt細胞及びその使用
WO2025212740A1 (en) * 2024-04-03 2025-10-09 Mink Therapeutics, Inc. Composition and methods for treating colorectal cancer liver metastasis (crc liver mets)

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010A (en) 1841-03-18 Machine foe
US62950A (en) 1867-03-19 Improvement in apparatus foe the manufacture of vinegar
JPS60222842A (ja) 1984-04-19 1985-11-07 Fuji Photo Film Co Ltd ハロゲン化銀写真乳剤およびその製造方法
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5182205A (en) 1986-11-27 1993-01-26 Hoffmann-La Roche Inc. Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor
DE3789138T2 (de) 1986-11-27 1994-05-26 Hoffmann La Roche Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck.
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9206318D0 (en) 1992-03-24 1992-05-06 Cambridge Antibody Tech Binding substances
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
WO1992018619A1 (en) 1991-04-10 1992-10-29 The Scripps Research Institute Heterodimeric receptor libraries using phagemids
US5871907A (en) 1991-05-15 1999-02-16 Medical Research Council Methods for producing members of specific binding pairs
US6225447B1 (en) 1991-05-15 2001-05-01 Cambridge Antibody Technology Ltd. Methods for producing members of specific binding pairs
US6492160B1 (en) 1991-05-15 2002-12-10 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US7067284B1 (en) 1992-01-27 2006-06-27 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US5233409A (en) 1992-02-25 1993-08-03 Schwab Karl W Color analysis of organic constituents in sedimentary rocks for thermal maturity
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9225453D0 (en) 1992-12-04 1993-01-27 Medical Res Council Binding proteins
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
US6326155B1 (en) 1995-03-20 2001-12-04 Dyax Corp. Engineering affinity ligands for macromolecules
ES2176484T3 (es) 1995-08-18 2002-12-01 Morphosys Ag Bancos de proteinas/(poli)peptidos.
US6706484B1 (en) 1995-08-18 2004-03-16 Morphosys Ag Protein/(poly)peptide libraries
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
GB9712818D0 (en) 1996-07-08 1997-08-20 Cambridge Antibody Tech Labelling and selection of specific binding molecules
WO1999006541A1 (fr) * 1997-07-29 1999-02-11 Sumitomo Electric Industries, Ltd. Anticorps du recepteur des cellules pre-b non humaines
JPH11133028A (ja) * 1997-10-29 1999-05-21 Sumitomo Electric Ind Ltd 抗ヒトプレb細胞レセプター抗体
US20030215453A1 (en) * 2002-05-14 2003-11-20 Dedera Douglas A. Methods of therapy and diagnosis using immunotargeting of cells expressing VpreB1 protein
GB2377997A (en) * 2001-07-24 2003-01-29 Bookham Technology Plc Connection of a non-perpendicular optical fibre to an optical device
JP4602614B2 (ja) 2001-09-26 2010-12-22 アイシン精機株式会社 自動車用ドア
ATE536376T1 (de) * 2003-12-23 2011-12-15 Crucell Holland Bv Humanes bindungsmolekül gegen cd1a
AU2007303572A1 (en) 2006-10-02 2008-04-10 Sea Lane Biotechnologies, Llc Design and construction of diverse synthetic peptide and polypeptide libraries
JP5779350B2 (ja) 2007-03-27 2015-09-16 シー レーン バイオテクノロジーズ, エルエルシー 抗体代替軽鎖配列を含む構築物およびライブラリー
CN102149727A (zh) 2008-07-11 2011-08-10 航道生物技术有限责任公司 包含抗体替代卡帕轻链序列的构建体和文库
EP3205723A1 (en) * 2009-06-26 2017-08-16 i2 Pharmaceuticals, Inc. Expression of surrogate light chains
IL269565B2 (en) * 2011-01-06 2024-06-01 Dyax Corp Plasma kallikrein binding proteins
WO2016126488A1 (en) 2015-02-02 2016-08-11 Sea Lane Biotechnologies, Llc Anti-surrogate light chain antibodies
WO2016127043A1 (en) * 2015-02-05 2016-08-11 Stc.Unm Anti-pre-bcr antagonists and methods

Similar Documents

Publication Publication Date Title
JP2018507254A5 (OSRAM)
WO2016207304A3 (en) Monoclonal anti-il-1racp antibodies
JP2017176174A5 (OSRAM)
JP2013506428A5 (OSRAM)
JP2016505634A5 (OSRAM)
CY1120414T1 (el) Αντισωματα που συνδεονται me οχ40 και οι χρησεις τους
JP2012143232A5 (OSRAM)
NZ716369A (en) Anti-ox40 antibodies and methods of using the same
FI3332006T3 (fi) Uusia anti-PD-L1-vasta-aineita
JP2020516603A5 (OSRAM)
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
NZ587198A (en) Monoclonal antibodies against the rgm a protein and uses thereof
FI3683235T3 (fi) Anti-IL-33-vasta-aineita ja niiden käyttöjä
JP2017518366A5 (OSRAM)
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
PE20071055A1 (es) Anticuerpos anti mn
JP2010513228A5 (OSRAM)
ES2572231T3 (es) Anticuerpos monoclonales anti-IL-21 humana
JP2021500916A5 (OSRAM)
JP2015527365A5 (OSRAM)
JP2010509937A5 (OSRAM)
EA201790816A1 (ru) Антитела, которые связываются с ccr6, и варианты применения указанных антител
JOP20210286A1 (ar) جسم مضاد أحادي النسيلة يرتبط نوعياً مع gitr
CY1118046T1 (el) Πρωτεϊνες δεσμευσης με αντιγονο ειδικες για το συστατικο ρ αμυλοειδους ορου
JP2018504903A5 (OSRAM)